HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kao/Kanebo end talks

This article was originally published in The Rose Sheet

Executive Summary

Japanese firms have ended discussions on Kao's planned acquisition of Kanebo's cosmetics business, Kao says Feb. 16. Plans fell through after Kanebo expressed decision to withdraw from negotiations, according to Kao. "We consider this news extremely unfortunate given our conviction that the plan for the transfer of business, which was in its final stages, was the most ideal option for Kanebo's employees, customers, partners, shareholders and others," Japanese consumer products marketer states. Negotiations hit a hurdle earlier this year when the two firms postponed finalization of a planned merger of their cosmetics businesses. Later, the companies tentatively agreed Kao would purchase Kanebo's cosmetics business outright instead (1"The Rose Sheet" Feb. 9, 2004, In Brief)...

You may also be interested in...



Kao acquires Kanebo

Japanese company purchases Kanebo for approximately $2.37 bil. (¥1=$.0084) in stock, Kao announces Dec. 16. Company will acquire $2.24 bil. in stock from Japan's Industrial Revitalization Corporation Jan. 31 and $132.6 mil. in stock from Kanebo in mid-February, firm notes. Acquisition aims to "create one of the world's foremost cosmetics business groups," according to Kao. Kanebo will become a wholly owned subsidiary but will remain an "independent organization" with no changes to management, Kao adds. Firm was in talks to buy Kanebo in 2004, but bowed out of negotiations, after which the company was taken over by government-run IRCJ (1"The Rose Sheet" March 1, 2004, In Brief and 2"The Rose Sheet" May 17, 2004, In Brief). Kanebo generated net sales of $1.3 bil. in the nine months ended Sept. 30, and is expected to achieve sales of $1.7 bil. for the year ended Dec. 31, Kao says...

Kanebo

Kanebo Cosmetics, Inc. is established by new financial backer, Industrial Revitalization Corporation of Japan, company announces May 7. Firm was spun off from parent Kanebo Ltd. after ICRJ purchased the cosmetic division's debt last month. New company "is aiming to tackle investment more actively and to maintain and strengthen competitiveness as well as pursue the goal of customer satisfaction through new concepts of beauty," according to Kanebo. Kunihiko Yogo, a director with the government agency, is appointed director and representative chairman/CEO under a new structure that emphasizes "a high level of transparency," firm says. Kanebo's management will now be divided among nomination, remuneration and auditing committees. The government bailout occurred after competitor Kao Corp. bowed out of negotiations to acquire Kanebo's cosmetics business earlier this year (1"The Rose Sheet" March 1, 2004, In Brief)...

Kao to buy Kanebo cosmetics

Kao plans to acquire Kanebo's cosmetics business, reshuffling earlier plans for a merger between the two Japanese cosmetics companies, Kao announces Jan. 31. While both companies are "continuing to exert deliberative efforts toward reaching a definitive agreement," a final decision on the transfer of the business will require more time, Kao says. An announcement on details of the plan will be made once the definitive agreement is signed, the firm adds. News comes just days after Kao reported it was postponing finalization of a merger with Kanebo (1"The Rose Sheet" Feb. 2, 2004, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel